Raymond James Downgrades Revolve Gr to Outperform, Raises Price Target to $78
Raymond James analyst Aaron Kessler downgrades Revolve Gr (NYSE:RVLV) from Strong Buy to Outperform and raises the price target from $61 to $78.
Keybanc Downgrades Revolve Gr to Sector Weight
Keybanc analyst Edward Yruma downgrades Revolve Gr (NYSE:RVLV) from Overweight to Sector Weight.
Revolve Group Q2 EPS $0.42 Beats $0.21 Estimate, Sales $228.61M Beat $198.87M Estimate
Revolve Group (NYSE:RVLV) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.21 by 100 percent. This is a 110 percent increase over earnings of $0.20 per share from the same
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
Where Revolve Gr Stands With Analysts
Revolve Gr (NYSE:RVLV) has observed the following analyst ratings within the last quarter:
Last 30 Days
1 Month Ago
2 Months Ago
MKM Partners Maintains Buy on Revolve Gr, Raises Price Target to $80
MKM Partners analyst Roxanne Meyer maintains Revolve Gr (NYSE:RVLV) with a Buy and raises the price target from $60 to $80.